The St. Gallen International Breast Cancer Conference (SGBCC) is one of the most authoritative and influential global events in the field of breast cancer, dedicated to advancing standardized diagnosis and treatment for early-stage breast cancer. To integrate international frontier concepts with domestic clinical practice and align China’s breast cancer care with global standards—ultimately delivering superior treatment options for patients—Professor Michael Gnant, President of SGBCC, visited The Second Hospital of Dalian Medical University on April 9 for a two-day academic exchange and collaboration initiative.
During the event, Professor Gnant was appointed as an Honorary Professor of The Second Hospital of Dalian Medical University and delivered a keynote lecture titled “SGBCC Key Updates.” He also engaged in in-depth discussions with Chinese experts on complex breast cancer cases and conducted consultations for three challenging patient cases at the hospital.
Professor Gnant shared internationally advanced perspectives on breast cancer management, emphasizing that future therapies will increasingly focus on personalization, integrating individual risk factors and treatment tolerance to optimize clinical outcomes.
v
